The Critical Role of Blood Sugar in the Third Trimester: Managing Gestational Diabetes

By Dr. Amit Tandon, MBBS, MS (Obs & Gynae), Fellowship in Robotic Surgery
Gynaecologist & Robotic Surgeon
Dr. Kamlesh Tandon Hospital, IVF Center & Robotic Surgery Centre, Agra

Introduction: Why the Third Trimester Demands Vigilance

The third trimester, spanning weeks 28 to 40, is a period of rapid fetal growth and metabolic change. For mothers with gestational diabetes mellitus (GDM), or those at risk of developing it, blood sugar control during this phase becomes paramount. Poorly managed glucose levels in late pregnancy can directly influence delivery outcomes, neonatal health, and the mother’s long-term metabolic risk.

Understanding Gestational Diabetes in Late Pregnancy

Gestational diabetes is defined as glucose intolerance with onset or first recognition during pregnancy. It affects approximately 14% of pregnancies worldwide. The third trimester is particularly significant because:

1. Insulin Resistance Peaks: Placental hormones like human placental lactogen, cortisol, and progesterone increase insulin resistance, which peaks at 32–36 weeks. The maternal pancreas must produce up to three times more insulin to maintain normal glucose.
2. Fetal Insulin Production Begins: After 20 weeks, the fetal pancreas starts producing insulin in response to maternal glucose that crosses the placenta. Excess maternal glucose leads to fetal hyperinsulinemia.

Maternal and Fetal Risks of Poorly Controlled Sugar in the Third Trimester

For the Mother:

• Preeclampsia: Women with GDM have a higher risk of hypertensive disorders.
• Polyhydramnios: Excess fetal urination from hyperglycemia increases amniotic fluid, raising risk of preterm labor.
• Cesarean Delivery: Fetal macrosomia often necessitates surgical delivery.
• Future Type 2 Diabetes: Up to 50% of women with GDM develop type 2 diabetes within 10 years.

For the Baby:

• Macrosomia: Birth weight >4 kg occurs in 15–45% of GDM pregnancies due to fetal hyperinsulinemia. This increases shoulder dystocia risk.
• Neonatal Hypoglycemia: After birth, the newborn’s high insulin levels persist while maternal glucose supply stops, causing blood sugar crashes.
• Respiratory Distress Syndrome: Hyperinsulinemia delays fetal lung maturity.
• Stillbirth: Risk increases in the last 4–8 weeks if glucose remains uncontrolled.

Evidence-Based Management in the Third Trimester

1. Monitoring Protocol
   The American College of Obstetricians and Gynecologists recommends self-monitoring of blood glucose four times daily: fasting and 1-hour or 2-hour postprandial. Target values:

• Fasting: <95 mg/dL
• 1-hour postprandial: <140 mg/dL
• 2-hour postprandial: <120 mg/dL

1. Medical Nutrition Therapy
   A dietitian-guided plan with 33–40% carbohydrates, 20% protein, and 40% fat is first-line therapy. Carbohydrates should be complex and distributed across three meals and two to three snacks to avoid glucose spikes.
2. Pharmacologic Intervention
   If targets are not met with diet and exercise within 1–2 weeks, insulin remains the gold standard. Metformin and glyburide are alternatives, but insulin does not cross the placenta.
3. Fetal Surveillance
   From 32 weeks, women with GDM require increased fetal monitoring, including non-stress tests and biophysical profiles. Ultrasound for fetal growth and amniotic fluid assessment is recommended every 4 weeks.
4. Timing of Delivery
   For well-controlled GDM, delivery at 39–40 weeks is advised. For poorly controlled GDM, delivery between 37–38+6 weeks may be considered to reduce stillbirth risk.

Why Choose Dr. Amit Tandon for High-Risk Pregnancy Care

Managing blood sugar in the third trimester requires precision, experience, and advanced technology. At Dr. Kamlesh Tandon Hospital, we provide:

• Expertise in High-Risk Obstetrics: With over 100 robotic gynecological surgeries completed, Dr. Amit Tandon combines surgical excellence with comprehensive antenatal care for GDM, preeclampsia, and previous cesarean pregnancies.
• Integrated Diabetes Care: In-house endocrinology consultation, certified diabetes educators, and nutritionists create personalized plans aligned with ACOG and DIPSI guidelines.
• Advanced Fetal Monitoring: 4D ultrasound, Doppler studies, and NST facilities ensure timely detection of macrosomia or growth restriction.
• Minimally Invasive Delivery Options: For patients with prior surgeries or complications, our robotic surgery center enables safer cesarean deliveries with faster recovery.
• Continuum of Care: From pre-conception counseling for PCOS and obesity to postpartum glucose testing, we focus on your long-term health.

Uncontrolled sugar in the last trimester is not just a number on a glucometer. It determines your delivery experience and your baby’s first breath. Partner with a team that understands both the science and the stakes.

Dr. Amit Tandon
Gynaecologist, IVF Specialist & Robotic Surgeon
Dr. Kamlesh Tandon Hospital, IVF Center & Robotic Surgery Centre
4/48, Lajpat Kunj, Bagh Farzana, Agra
Ph: 7078432277

---

References:

1. American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 190: Gestational Diabetes Mellitus. Obstet Gynecol. 2018;131(2):e49-e64.
2. International Diabetes Federation. IDF Diabetes Atlas, 10th ed. Brussels, Belgium: 2021.
3. Metzger BE, et al. Hyperglycemia and Adverse Pregnancy Outcomes. N Engl J Med. 2008;358(19):1991-2002.
4. Diabetes in Pregnancy Study Group India. DIPSI Guidelines for GDM. J Assoc Physicians India. 2019.
5. National Institute for Health and Care Excellence. Diabetes in pregnancy: management from preconception to the postnatal period. NICE Guideline. 2020.[NG3]